102 related articles for article (PubMed ID: 32634485)
1. Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial.
Reichman M; Riklin E; Macklin E; Vranceanu AM
Contemp Clin Trials; 2020 Aug; 95():106078. PubMed ID: 32634485
[TBL] [Abstract][Full Text] [Related]
2. Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
Vranceanu AM; Zale EL; Funes CJ; Macklin EA; McCurley J; Park ER; Jordan JT; Lin A; Plotkin SR
JMIR Res Protoc; 2018 Oct; 7(10):e11008. PubMed ID: 30355560
[TBL] [Abstract][Full Text] [Related]
3. Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program.
Lester EG; Macklin EA; Plotkin S; Vranceanu AM
J Neurooncol; 2020 Apr; 147(2):451-457. PubMed ID: 32078086
[TBL] [Abstract][Full Text] [Related]
4. Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: A pilot randomized controlled trial.
Lester E; DiStefano S; Mace R; Macklin E; Plotkin S; Vranceanu AM
Gen Hosp Psychiatry; 2020; 62():72-78. PubMed ID: 31841875
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of a Live Video Mind-Body Program to a Web-Based Platform for English-Speaking Adults With Neurofibromatosis: Protocol for the NF-Web Study.
Lester EG; Hopkins SW; Popok PJ; Vranceanu AM
JMIR Res Protoc; 2021 Jun; 10(6):e27526. PubMed ID: 34110294
[TBL] [Abstract][Full Text] [Related]
6. Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.
Vranceanu AM; Manglani HR; Choukas NR; Kanaya MR; Lester E; Zale EL; Plotkin SR; Jordan J; Macklin E; Bakhshaie J
JAMA Netw Open; 2023 Jun; 6(6):e2320599. PubMed ID: 37378983
[TBL] [Abstract][Full Text] [Related]
7. Resilient youth with neurofibromatosis: Less perceived stress and greater life satisfaction after an 8-week virtual mind-body intervention.
Lester E; Vranceanu AM
J Psychosoc Oncol; 2021; 39(5):680-685. PubMed ID: 33191871
[TBL] [Abstract][Full Text] [Related]
8. Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.
Mace RA; Doorley J; Bakhshaie J; Cohen JE; Vranceanu AM
J Neurooncol; 2021 Nov; 155(2):125-132. PubMed ID: 34570301
[TBL] [Abstract][Full Text] [Related]
9. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
Presciutti AM; Lester EG; Woodworth EC; Greenberg J; Bakhshaie J; Hooker JE; McDermott KA; Vranceanu AM
J Neurooncol; 2023 Jul; 163(3):707-716. PubMed ID: 37440099
[TBL] [Abstract][Full Text] [Related]
10. Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial.
Fishbein NS; Vranceanu AM; Mace RA
J Neurooncol; 2022 Sep; 159(3):637-646. PubMed ID: 35925531
[TBL] [Abstract][Full Text] [Related]
11. Mind-body therapy via videoconferencing in patients with neurofibromatosis: An RCT.
Vranceanu AM; Riklin E; Merker VL; Macklin EA; Park ER; Plotkin SR
Neurology; 2016 Aug; 87(8):806-14. PubMed ID: 27449066
[TBL] [Abstract][Full Text] [Related]
12. Mind-Body Therapy via Videoconferencing in Patients With Neurofibromatosis: Analyses of 1-Year Follow-up.
Lester EG; Gates MV; Vranceanu AM
Ann Behav Med; 2021 Feb; 55(1):77-81. PubMed ID: 32421171
[TBL] [Abstract][Full Text] [Related]
13. The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis.
Zale EL; Pierre-Louis C; Macklin EA; Riklin E; Vranceanu AM
J Neurooncol; 2018 Apr; 137(2):321-329. PubMed ID: 29275505
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and Severity of Suicidal Ideation in Adults With Neurofibromatosis Participating in a Mind-Body RCT.
Lester EG; Wang KE; Blakeley JO; Vranceanu AM
Cogn Behav Neurol; 2023 Mar; 36(1):19-27. PubMed ID: 36651958
[TBL] [Abstract][Full Text] [Related]
15. Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.
Carter S; Greenberg J; Funes CJ; Macklin EA; Vranceanu AM
Complement Ther Med; 2021 Jan; 56():102581. PubMed ID: 33197677
[TBL] [Abstract][Full Text] [Related]
16. Home practice and quality of life among patients with neurofibromatosis randomized to a mind-body intervention.
Funes CJ; Zale EL; Luberto CM; Vranceanu AM
Complement Ther Med; 2019 Feb; 42():114-118. PubMed ID: 30670227
[TBL] [Abstract][Full Text] [Related]
17. The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis.
McDermott K; Bakhshaie J; Brewer J; Vranceanu AM
Am J Med Genet A; 2024 Jun; 194(6):e63543. PubMed ID: 38318960
[TBL] [Abstract][Full Text] [Related]
18. Minimal clinically important difference in the World Health Organization Quality of Life Brief (WHOQOL-BREF) for adults with neurofibromatosis.
Pietrzykowski MO; Vranceanu AM; Macklin EA; Mace RA
Qual Life Res; 2024 May; 33(5):1233-1240. PubMed ID: 38214851
[TBL] [Abstract][Full Text] [Related]
19. Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.
Kanaya MR; Greenberg J; Bakhshaie J; Vranceanu AM
J Neurooncol; 2024 Apr; 167(2):315-322. PubMed ID: 38409461
[TBL] [Abstract][Full Text] [Related]
20. Impact of mind-body treatment interventions on quality of life in neurofibromatosis patients: A systematic review and meta-analysis.
Wei G; Farooq J; Kumar A
Dermatol Ther; 2021 Jan; 34(1):e14613. PubMed ID: 33258517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
